Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Niederman

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Critical Care (London, England)|February 8, 2005
Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team?Jean-Louis Vincent, Christian Brun-Buisson, Michael Niederman, et al.
Annals of the American Thoracic Society|December 2, 2020
Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial PneumoniaCristina Dominedò, Adrian Ceccato, Michael Niederman, et al.
Current Medical Research and Opinion|June 14, 2008
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter studyAlvaro Réa-Neto, Michael Niederman, Suzana Margareth Lobo, et al.
The European Respiratory Journal|January 24, 2015
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosisAntoni Torres, Catia Cillóniz, Miquel Ferrer, et al.
Intensive Care Medicine|February 2, 2019
Challenges in severe community-acquired pneumonia: a point-of-view reviewAntoni Torres, James D Chalmers, Charles S Dela Cruz, et al.
The European Respiratory Journal|April 23, 2016
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumoniaAdamantia Liapikou, Catia Cillóniz, Albert Gabarrús, et al.
Critical Care (London, England)|July 24, 2014
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusDipen A Patel, Andrew F Shorr, Jean Chastre, et al.
Critical Care Medicine|August 31, 2013
Assessment of severity of ICU-acquired pneumonia and association with etiologyMarta Di Pasquale, Miquel Ferrer, Mariano Esperatti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2008
Guideline tyranny: a response to the article by Baum and KaltsasLionel Mandell, Richard Wunderink, Antonio Anzueto, et al.
Ebiomedicine|April 4, 2026
Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trialEmmanouil Stylianakis, Nikolaos Kakavoulis, Spyros Foutadakis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Critical Care (London, England)|February 8, 2005
Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team?Jean-Louis Vincent, Christian Brun-Buisson, Michael Niederman, et al.
Annals of the American Thoracic Society|December 2, 2020
Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial PneumoniaCristina Dominedò, Adrian Ceccato, Michael Niederman, et al.
Current Medical Research and Opinion|June 14, 2008
Efficacy and safety of doripenem versus piperacillin/tazobactam in nosocomial pneumonia: a randomized, open-label, multicenter studyAlvaro Réa-Neto, Michael Niederman, Suzana Margareth Lobo, et al.
The European Respiratory Journal|January 24, 2015
Bacteraemia and antibiotic-resistant pathogens in community acquired pneumonia: risk and prognosisAntoni Torres, Catia Cillóniz, Miquel Ferrer, et al.
Intensive Care Medicine|February 2, 2019
Challenges in severe community-acquired pneumonia: a point-of-view reviewAntoni Torres, James D Chalmers, Charles S Dela Cruz, et al.
The European Respiratory Journal|April 23, 2016
Multilobar bilateral and unilateral chest radiograph involvement: implications for prognosis in hospitalised community-acquired pneumoniaAdamantia Liapikou, Catia Cillóniz, Albert Gabarrús, et al.
Critical Care (London, England)|July 24, 2014
Modeling the economic impact of linezolid versus vancomycin in confirmed nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureusDipen A Patel, Andrew F Shorr, Jean Chastre, et al.
Critical Care Medicine|August 31, 2013
Assessment of severity of ICU-acquired pneumonia and association with etiologyMarta Di Pasquale, Miquel Ferrer, Mariano Esperatti, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 20, 2008
Guideline tyranny: a response to the article by Baum and KaltsasLionel Mandell, Richard Wunderink, Antonio Anzueto, et al.
Ebiomedicine|April 4, 2026
Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trialEmmanouil Stylianakis, Nikolaos Kakavoulis, Spyros Foutadakis, et al.
Pageof 3